A. Parquet

发表

French Previously Untreated Patients with Severe Hemophilia A after Exposure to Recombinant Factor VIII : Incidence of Inhibitor and Evaluation of Immune Tolerance

P. Moreau, C. Rothschild, J. Goudemand, 1998, Thrombosis and Haemostasis.

Incidence of Factor IX Inhibitor Development in Severe Haemophilia B Patients Treated with only one Brand of High Purity Plasma Derived Factor IX Concentrate

C. Rothschild, V. Gay, C. Guérois, 1999, Thrombosis and Haemostasis.

A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.

C. Legrand, J. Rosa, A. Parquet, 1987, The Journal of clinical investigation.

Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII‐binding capacity

R. Favier, J. Goudemand, É. Fressinaud, 2003, British journal of haematology.

Comparison of Anti‐Human and Anti‐Porcine Factor VIII Inhibitor Levels in 63 Patients with Severe Haemophilia A

M. Torchet, M. Bertrand, B. Boneu, 1993, Vox sanguinis.

Total knee arthroplasty in hemophilic arthropathy.

F. Gougeon, A. Parquet, I. Legroux-Gérot, 2003, Joint, bone, spine : revue du rhumatisme.

Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A.

K. Baumstarck, P. Moreau, T. Lambert, 2021, The Journal of pediatrics.

Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.

Y. Laurian, A. Parquet, G. Tchernia, 1994, Nouvelle revue francaise d'hematologie.

Comparison of Anti-Human and Anti-Porcine Factor Vlll Inhibitor

M. Torchet, M. Bertrand, B. Boneu, 2009 .

[Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia].

C. Guérois, Y. Laurian, M. Vicariot, 1991, Presse medicale.

Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma‐derived FVIII or FIX concentrate: results from the French haemophilia cohort

D. Costagliola, S. Claeyssens, A. Parquet, 2002, British journal of haematology.

Identification of new type 2B von Willebrand disease mutations: Arg543Gln, Arg545Pro and Arg578Leu

J. Abgrall, A. Parquet, C. Mazurier, 1998, British journal of haematology.

Hepatitis A in French Hemophiliacs

J. Fonlupt, J. Goudemand, C. Négrier, 1994, Vox sanguinis.

Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.

J. Cazenave, B. Boneu, Y. Sultan, 1988, Nouvelle revue francaise d'hematologie.